NRSG 2350 NORTH EASTERN UNIVERSITY FINAL EXAM– QUESTIONS AND ANSWERS | VERIFIED AND WELL
DETAILED ANSWERS | PLUS RATIONALES | DOWNLOAD AND PASS | LATEST EXAM UPDATE 2026/2027
Core Domains
Integrated Pathophysiology and Pharmacology
Endocrine System Disorders and Pharmacological Interventions
Hematologic and Oncologic Disorders and Pharmacological Interventions
Neurologic Disorders and Pharmacological Interventions
Cardiovascular Disorders and Pharmacological Interventions
Respiratory Disorders and Pharmacological Interventions
Renal and Gastrointestinal Disorders and Pharmacological Interventions
Cellular Function, Fluid, and Electrolyte Balance
Immunity and Inflammation
Nursing Process, Ethics, and Regulatory Compliance
,Introduction
This comprehensive final examination assesses mastery of integrated pathophysiology and pharmaceutical
interventions essential for nursing practice. The examination evaluates foundational theoretical knowledge and applied
professional judgment through multiple-choice and scenario-based questions. Critical thinking, clinical decision-
making, and real-world application of pharmacological principles are emphasized throughout. Ethical considerations,
regulatory compliance, and safe medication practices are integrated into assessment items. This examination prepares
candidates for professional licensure by requiring synthesis of pathophysiologic mechanisms with pharmacologic
management across diverse patient populations and clinical settings. Candidates must demonstrate competency in
nursing assessment, intervention, and evaluation to ensure safe, effective, patient-centered care.
SECTION ONE: QUESTIONS 1–50
Question 1
A client with type 1 diabetes mellitus presents with polyuria, polydipsia, and polyphagia. Which pathophysiologic
mechanism is responsible for these classic manifestations?
A. Excess insulin production causing rapid cellular glucose uptake
B. Hyperglycemia causing osmotic diuresis and cellular starvation
C. Increased glucagon secretion stimulating appetite centers
,D. Decreased renal threshold for glucose reabsorption
🟢 Correct Answer: B. Hyperglycemia causing osmotic diuresis and cellular starvation
🔴 Explanation: In type 1 diabetes, insufficient insulin leads to hyperglycemia. Glucose exceeds the renal threshold,
causing osmotic diuresis (polyuria). Fluid loss triggers polydipsia. Cellular inability to utilize glucose causes
polyphagia.
Question 2
A client with type 2 diabetes is prescribed metformin. The nurse understands that this medication works primarily by
which mechanism?
A. Stimulating pancreatic insulin release
B. Decreasing hepatic glucose production and increasing insulin sensitivity
C. Slowing carbohydrate absorption in the gastrointestinal tract
D. Directly increasing glucose uptake in skeletal muscle independent of insulin
🟢 Correct Answer: B. Decreasing hepatic glucose production and increasing insulin sensitivity
, 🔴 Explanation: Metformin is a biguanide that reduces hepatic gluconeogenesis and improves peripheral insulin
sensitivity. It does not stimulate insulin secretion, making it safe in terms of hypoglycemia risk.
Question 3
A client diagnosed with Graves' disease is initiated on methimazole. Which adverse effect requires immediate
medical attention?
A. Bradycardia
B. Agranulocytosis
C. Weight gain
D. Cold intolerance
🟢 Correct Answer: B. Agranulocytosis
🔴 Explanation: Methimazole can cause agranulocytosis, a life-threatening reduction in white blood cells. Clients
must be instructed to report fever, sore throat, or signs of infection immediately.
Question 4
DETAILED ANSWERS | PLUS RATIONALES | DOWNLOAD AND PASS | LATEST EXAM UPDATE 2026/2027
Core Domains
Integrated Pathophysiology and Pharmacology
Endocrine System Disorders and Pharmacological Interventions
Hematologic and Oncologic Disorders and Pharmacological Interventions
Neurologic Disorders and Pharmacological Interventions
Cardiovascular Disorders and Pharmacological Interventions
Respiratory Disorders and Pharmacological Interventions
Renal and Gastrointestinal Disorders and Pharmacological Interventions
Cellular Function, Fluid, and Electrolyte Balance
Immunity and Inflammation
Nursing Process, Ethics, and Regulatory Compliance
,Introduction
This comprehensive final examination assesses mastery of integrated pathophysiology and pharmaceutical
interventions essential for nursing practice. The examination evaluates foundational theoretical knowledge and applied
professional judgment through multiple-choice and scenario-based questions. Critical thinking, clinical decision-
making, and real-world application of pharmacological principles are emphasized throughout. Ethical considerations,
regulatory compliance, and safe medication practices are integrated into assessment items. This examination prepares
candidates for professional licensure by requiring synthesis of pathophysiologic mechanisms with pharmacologic
management across diverse patient populations and clinical settings. Candidates must demonstrate competency in
nursing assessment, intervention, and evaluation to ensure safe, effective, patient-centered care.
SECTION ONE: QUESTIONS 1–50
Question 1
A client with type 1 diabetes mellitus presents with polyuria, polydipsia, and polyphagia. Which pathophysiologic
mechanism is responsible for these classic manifestations?
A. Excess insulin production causing rapid cellular glucose uptake
B. Hyperglycemia causing osmotic diuresis and cellular starvation
C. Increased glucagon secretion stimulating appetite centers
,D. Decreased renal threshold for glucose reabsorption
🟢 Correct Answer: B. Hyperglycemia causing osmotic diuresis and cellular starvation
🔴 Explanation: In type 1 diabetes, insufficient insulin leads to hyperglycemia. Glucose exceeds the renal threshold,
causing osmotic diuresis (polyuria). Fluid loss triggers polydipsia. Cellular inability to utilize glucose causes
polyphagia.
Question 2
A client with type 2 diabetes is prescribed metformin. The nurse understands that this medication works primarily by
which mechanism?
A. Stimulating pancreatic insulin release
B. Decreasing hepatic glucose production and increasing insulin sensitivity
C. Slowing carbohydrate absorption in the gastrointestinal tract
D. Directly increasing glucose uptake in skeletal muscle independent of insulin
🟢 Correct Answer: B. Decreasing hepatic glucose production and increasing insulin sensitivity
, 🔴 Explanation: Metformin is a biguanide that reduces hepatic gluconeogenesis and improves peripheral insulin
sensitivity. It does not stimulate insulin secretion, making it safe in terms of hypoglycemia risk.
Question 3
A client diagnosed with Graves' disease is initiated on methimazole. Which adverse effect requires immediate
medical attention?
A. Bradycardia
B. Agranulocytosis
C. Weight gain
D. Cold intolerance
🟢 Correct Answer: B. Agranulocytosis
🔴 Explanation: Methimazole can cause agranulocytosis, a life-threatening reduction in white blood cells. Clients
must be instructed to report fever, sore throat, or signs of infection immediately.
Question 4
